Genprex (GNPX) EPS (Basic) Growth (3y) (2019 - 2025)
Genprex (GNPX) EPS (Basic) Growth (3y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn | 6.85% |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn | 11.71% |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | 64.84% |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn | 18.44% |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn | 37.21% |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn | 36.73% |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn | -26.87% |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 67.51% |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | -38.31% |
| 10 | Genprex | 1.91 Mn | -13.25 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 78.29% |
| Dec 31, 2024 | 43.14% |
| Sep 30, 2024 | 24.52% |
| Jun 30, 2024 | 3.52% |
| Mar 31, 2024 | 7.33% |
| Dec 31, 2023 | 9.60% |
| Sep 30, 2023 | -23.66% |
| Jun 30, 2023 | -7.63% |
| Mar 31, 2023 | 2.05% |
| Dec 31, 2022 | 3.40% |
| Sep 30, 2022 | 5.02% |
| Jun 30, 2022 | 20.05% |
| Mar 31, 2022 | 7.60% |
| Dec 31, 2021 | 17.04% |
| Sep 30, 2021 | 21.41% |
| Jun 30, 2021 | 42.77% |
| Mar 31, 2021 | -25.44% |
| Dec 31, 2020 | -36.38% |
| Sep 30, 2020 | 38.59% |
| Jun 30, 2020 | -5.26% |